AbCellera Biologics Inc.

ABCL · Healthcare · $4.5B

$14.22-2.54%

Price

$8.11

$14.00

Jul 2, 26Oct 1, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$8M+88.2%

6/'26 vs prev quarter

Company Health

Market Cap$4.5B

Operating Margin-340.3%

Cash on Hand$540M12.1% of market cap

Free Cash Flow$-82M-1.8% of market cap

Short Float 16.5% · biweekly · settled 26.09.15

Among 327 Biotechnology peers

LowMedianHigh

PSR67.3xmedian 11.7xPBR5.0xmedian 2.1xROE-18.4%median -54.5%